Recent developments in the treatment of non-metastatic castration resistant prostate cancer
Non-metastatic castration resistant prostate cancer (nmCRPC) is defined as a disease state withlack of topo designs cooler bag radiographic evidence of metastatic disease, a confirmed rising PSA level on continuous ADT and maintaining a castrate level of testosterone following definitive therapy.Prior to the publication of PROSPER, SPARTAN and ARAM